{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:55:15Z","timestamp":1792428915520,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12105-021-01329-1","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T08:03:14Z","timestamp":1619769794000},"page":"1185-1191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-5517","authenticated-orcid":false,"given":"Vincent","family":"Cracolici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Snyderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey M.","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simion","family":"Chiosea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatur D.","family":"Singhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja R.","family":"Seethala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"issue":"1","key":"1329_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1006\/bbrc.1993.1412","volume":"192","author":"YC Patel","year":"1993","unstructured":"Patel YC, Greenwood M, Kent G, et al. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem Biophys Res Commun. 1993;192(1):288\u201394.","journal-title":"Biochem Biophys Res Commun"},{"key":"1329_CR2","unstructured":"The Human Protein Atlas [internet]. Human Protein Somatostatin Receptor 2; SSTR2. https:\/\/www.proteinatlas.org\/ENSG00000180616-SSTR2\/tissue. Accessed 24 Sept 2020"},{"issue":"1","key":"1329_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/gut.50.1.52","volume":"50","author":"H Kulaksiz","year":"2002","unstructured":"Kulaksiz H, Eissele R, Rossler D, et al. Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut. 2002;50(1):52\u201360.","journal-title":"Gut"},{"issue":"11","key":"1329_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/modpathol.3800954","volume":"20","author":"M Volante","year":"2007","unstructured":"Volante M, Brizzi MP, Faggiano A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol. 2007;20(11):1172\u201382.","journal-title":"Mod Pathol"},{"issue":"3","key":"1329_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000330616","volume":"95","author":"HA Schmid","year":"2012","unstructured":"Schmid HA, Lambertini C, van Vugt HH, et al. Monoclonal antibodies against the human somatostatin receptor subtypes 1\u20135: development and immunohistochemical application in neuroendocrine tumors. Neuroendocrinology. 2012;95(3):232\u201347.","journal-title":"Neuroendocrinology"},{"issue":"10","key":"1329_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.endonu.2014.05.006","volume":"61","author":"B Gonzalez","year":"2014","unstructured":"Gonzalez B, Vargas G, Ramirez C, et al. Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT\/PCR is not associated with the pharmacological response to octreotide. Endocrinologia y nutricion\u202f: organo de la Sociedad Espanola de Endocrinologia y Nutricion. 2014;61(10):523\u201330.","journal-title":"Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion"},{"issue":"3","key":"1329_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/cen.12775","volume":"83","author":"E Diakatou","year":"2015","unstructured":"Diakatou E, Alexandraki KI, Tsolakis AV, et al. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores. Clin Endocrinol. 2015;83(3):420\u20138.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1329_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5603\/NMR.2016.0022","volume":"19","author":"J Hankus","year":"2016","unstructured":"Hankus J, Tomaszewska R. Neuroendocrine neoplasms and somatostatin receptor subtypes expression. Nucl Med Rev Cent East Eur. 2016;19(2):111\u20137.","journal-title":"Nucl Med Rev Cent East Eur"},{"issue":"10","key":"1329_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1369\/0022155419856900","volume":"67","author":"SM Remes","year":"2019","unstructured":"Remes SM, Leijon HL, Vesterinen TJ, et al. Immunohistochemical expression of somatostatin receptor subtypes in a panel of neuroendocrine neoplasias. J Histochem Cytochem. 2019;67(10):735\u201343.","journal-title":"J Histochem Cytochem"},{"issue":"Suppl 2","key":"1329_CR10","first-page":"S190","volume":"31","author":"A Chiti","year":"1999","unstructured":"Chiti A, van Graafeiland BJ, Savelli G, et al. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues. Ital J Gastroenterol Hepatol. 1999;31(Suppl 2):S190-194.","journal-title":"Ital J Gastroenterol Hepatol"},{"issue":"7","key":"1329_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00003072-200307000-00003","volume":"28","author":"S Fanti","year":"2003","unstructured":"Fanti S, Farsad M, Battista G, et al. Somatostatin receptor scintigraphy for bronchial carcinoid follow-up. Clin Nucl Med. 2003;28(7):548\u201352.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"1329_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/00005537-200403000-00010","volume":"114","author":"A Bustillo","year":"2004","unstructured":"Bustillo A, Telischi F, Weed D, et al. Octreotide scintigraphy in the head and neck. Laryngoscope. 2004;114(3):434\u201340.","journal-title":"Laryngoscope"},{"issue":"5","key":"1329_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00006231-200405000-00004","volume":"25","author":"G Savelli","year":"2004","unstructured":"Savelli G, Lucignani G, Seregni E, et al. Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours. Nucl Med Commun. 2004;25(5):445\u20139.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"1329_CR14","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1677\/ERC-09-0078","volume":"17","author":"DJ Kwekkeboom","year":"2010","unstructured":"Kwekkeboom DJ, Kam BL, van Essen M, et al. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Endocr Relat Cancer. 2010;17(1):R53-73.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"1329_CR15","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.7150\/thno.31806","volume":"9","author":"CM Waldmann","year":"2019","unstructured":"Waldmann CM, Stuparu AD, van Dam RM, et al. The search for an alternative to (68)Ga-DOTA-TATE in neuroendocrine tumor theranostics: current state of (18)F-labeled somatostatin analog Ddevelopment. Theranostics. 2019;9(5):1336\u201347.","journal-title":"Theranostics"},{"key":"1329_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/102819","author":"L Wang","year":"2013","unstructured":"Wang L, Tang K, Zhang Q, et al. Somatostatin receptor-based molecular imaging and therapy for neuroendocrine tumors. BioMed Res Int. 2013. https:\/\/doi.org\/10.1155\/2013\/102819.","journal-title":"BioMed Res Int"},{"issue":"6","key":"1329_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ons\/opy028","volume":"15","author":"JR Schneider","year":"2018","unstructured":"Schneider JR, Shatzkes DR, Scharf SC, et al. Neuroradiological and neuropathological changes after 177Lu-Octreotate peptide receptor radionuclide therapy of refractory esthesioneuroblastoma. Op Neurosurg. 2018;15(6):100\u20139.","journal-title":"Op Neurosurg"},{"issue":"15","key":"1329_CR18","first-page":"690","volume":"24","author":"M Zeng","year":"2010","unstructured":"Zeng M, Cui Y, Wu C. Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma. J Clin Otorhinolaryngol Head Neck Surg. 2010;24(15):690\u20132.","journal-title":"J Clin Otorhinolaryngol Head Neck Surg"},{"key":"1329_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.humpath.2018.05.013","volume":"79","author":"P Czapiewski","year":"2018","unstructured":"Czapiewski P, Kunc M, Gorczy\u0144ski A, et al. Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature. Hum Pathol. 2018;79:144\u201350.","journal-title":"Hum Pathol"},{"issue":"12","key":"1329_CR20","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1017\/S0022215100136023","volume":"110","author":"HA Ramsay","year":"1996","unstructured":"Ramsay HA, Kairemo KJ, Jekunen AP. Somatostatin receptor imaging of olfactory neuroblastoma. J Laryngol Otol. 1996;110(12):1161\u20133.","journal-title":"J Laryngol Otol"},{"issue":"10","key":"1329_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s002590050314","volume":"25","author":"A Chiti","year":"1998","unstructured":"Chiti A, Fanti S, Savelli G, et al. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med. 1998;25(10):1396\u2013403.","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"1329_CR22","first-page":"367","volume":"18","author":"A Garc\u00eda Vicente","year":"1999","unstructured":"Garc\u00eda Vicente A, Garc\u00eda Del Castillo E, Soriano Castrej\u00f3n A, et al. Olfactory esthesioneuroblastoma: scintigraphic expression of somatostatin receptors. Revista Espanola de Medicina Nuclear. 1999;18(5):367\u201370.","journal-title":"Revista Espanola de Medicina Nuclear"},{"issue":"1","key":"1329_CR23","first-page":"61","volume":"43","author":"SR Freeman","year":"2005","unstructured":"Freeman SR, Mitra S, Malik TH, et al. Expression of somatostatin receptors in arginine vasopressin hormone-secreting olfactory neuroblastoma\u2013report of two cases. Rhinology. 2005;43(1):61\u20135.","journal-title":"Rhinology"},{"issue":"4","key":"1329_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/hed.20356","volume":"28","author":"RC Rostomily","year":"2006","unstructured":"Rostomily RC, Elias M, Deng M, et al. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression. Head Neck. 2006;28(4):305\u201312.","journal-title":"Head Neck"},{"issue":"3","key":"1329_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11060-016-2067-3","volume":"127","author":"G Savelli","year":"2016","unstructured":"Savelli G, Bartolomei M, Bignardi M. Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach. J Neuro-oncol. 2016;127(3):617\u20139.","journal-title":"J Neuro-oncol"},{"issue":"4","key":"1329_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/RLU.0000000000000705","volume":"40","author":"W Makis","year":"2015","unstructured":"Makis W, McCann K, McEwan AJ. Esthesioneuroblastoma (olfactory neuroblastoma) treated with 111In-octreotide and 177Lu-DOTATATE PRRT. Clin Nucl Med. 2015;40(4):317\u201321.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"1329_CR27","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.3892\/etm.2016.3732","volume":"12","author":"JG Sabongi","year":"2016","unstructured":"Sabongi JG, Gon\u00e7alves MC, Alves CD, et al. Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: a case report. Exp Ther Med. 2016;12(5):3078\u201382.","journal-title":"Exp Ther Med"},{"issue":"9","key":"1329_CR28","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.2967\/jnumed.119.237990","volume":"61","author":"O Kamel Hasan","year":"2020","unstructured":"Kamel Hasan O, Ravi Kumar AS, Kong G, et al. Efficacy of peptide receptor radionuclide therapy for esthesioneuroblastoma. J Nucl Med. 2020;61(9):1326\u201330.","journal-title":"J Nucl Med"},{"issue":"S2","key":"1329_CR29","first-page":"328A","volume":"31","author":"SK Mardekian","year":"2017","unstructured":"Mardekian SK, Snyderman CH, Pollack AZ, et al. The value of Hyams grade in an endoscopically treated cohort of olfactory neuroblastoma. Mod Pathol. 2017;31(S2):328A.","journal-title":"Mod Pathol"},{"issue":"5","key":"1329_CR30","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/bcr3486","volume":"15","author":"H Ma","year":"2013","unstructured":"Ma H, Lu Y, Marchbanks PA, et al. Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women. Breast Cancer Res. 2013;15(5):R90.","journal-title":"Breast Cancer Res"},{"key":"1329_CR31","first-page":"410","volume":"13","author":"L Berger","year":"1924","unstructured":"Berger L, Luc R. L\u2019esth\u00e9sioneuro\u00e9pith\u00e9liome olfactif. Bull Assoc Franc P L\u2019etude du Cancer. 1924;13:410\u201321.","journal-title":"Bull Assoc Franc P L\u2019etude du Cancer"},{"issue":"12","key":"1329_CR32","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1097\/PAS.0b013e3182363b78","volume":"35","author":"JC Wooff","year":"2011","unstructured":"Wooff JC, Weinreb I, Perez-Ordonez B, et al. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol. 2011;35(12):1786\u201393.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1329_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00428-020-02815-7","volume":"477","author":"L Tao","year":"2020","unstructured":"Tao L, Chen Y, Shi X, et al. Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma. Virchows Arch. 2020;477(4):573\u20139.","journal-title":"Virchows Arch"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-021-01329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-021-01329-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-021-01329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T21:45:10Z","timestamp":1672004710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-021-01329-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1007\/s12105-021-01329-1","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"15 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest relevant to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors consent to publication in the present form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"This research study was conducted retrospectively from data gathered for clinical purposes. This study was and approved by the University of Pittsburgh IRB (PRO14080496). Consent is waived due to the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}